Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00047294

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cancer Center at the University of Virginia Charlottesville, Virginia, United States
View Trial Details
Completed

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

NCT00823797

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +22 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Informed Consent in Pediatric Cancer Trials

NCT00923650

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumors, +25 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Cleveland Clinic Foundation Childrens Hospital Cleveland, Ohio, United States
View Trial Details
Completed

Amgen 386 for Recurrent Glioblastoma

NCT01290263

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Massachusetts General Hosptial Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Massachusetts, Worcester Worcester, Massachusetts, United States
View Trial Details

Related conditions